Redcare Pharmacy NV (XTER:RDC)
€ 135.9 -1.6 (-1.16%) Market Cap: 2.70 Bil Enterprise Value: 2.76 Bil PE Ratio: 0 PB Ratio: 5.38 GF Score: 79/100

Half Year 2024 Redcare Pharmacy NV Earnings Call Transcript

Jul 30, 2024 / 09:00AM GMT
Release Date Price: €145.3 (+9.33%)
Olaf Heinrich
Redcare Pharmacy NV - Chief Executive Officer, Member of the Management Board

Thank you very much and good morning to everybody. Also very warm welcome from my side. As some of you who are joining via webcast, probably just saw commercials on our X. We are currently running. So we thought this is a nice intro and the other day.

So let's have a look into the agenda of today. The standard agenda. Firstly, Scott, with financial performance during the strategy update on 2024 and outlook and guidance. If we look into the financial performance, we would like to start with some highlights from We continue our fast grow at a 42%. And even if we exclude managed services, we are showing a growth above 20%. So to be more specific, it's 21% we are very happy to report strong growth on Europe, as you all aware of and direct became mandatory at the beginning of this year. And since then, we have seen really great adaptation from a doctor's perspective. So more than 80% of the scripts being issued in Germany are already difficult since the launch of our cutting solution on May sixth, we have seen

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot